Diseases and Poorly Organized Syllabus Materials Flashcards
Influenza
orthomyxoviridae, new viral outbreaks every year, have a dsRNA intermediate in host cells
first site of entry: influenza
lung epithelial cells (epithelial attempts prevention via release of fatty acids, anti-microbial peptides, and enzymes)
epithelial cell response to infection
IL-1 release (increases local heat, activates cells) and TNF release (increase in vascular permeability, integrin activation fluid release and protein release)
WBC
4,000 - 11,000
lymphocytes (how many)
1,000 - 4,000
APECED
occurs from mutations in AIRE, “so that tissue specific antigens needed to tolerize T cell in the thymus are not expressed”; therefore auto-reactive T cells leave the thymus.
mutations in fas/fasl
cause a mutation and a “lymphoproliferative” disorder in which T cells are activated and expand uncontrollably
immunodeficiency disease from B cell problems
mutations in Igμ, mutations in the surrogate light chain, mutations in CD79: all three are rare
flow cytometry and immunohistochemistry in relation to B cells
can be used to determine the development of B cell tumors
B cell depletion therapy
targets CD20, FDA approved in patients with autoimmune diseases
Abatacept
CTLA4-Ig: blocks CD80/CD86 - CD28 interactions – for autoimmune disease treatment
AID and CD40L deficiencies cause
Hyper IgM syndrome (inability to cause the B cell to class switch) – treated with IVIG
CVID
Common Variable Immunodeficiency: from ICOSL/ICOS deficiency (needed for germinal center formation)
acute lymphoblastic leukemia
pre-B cell tumor (think VpreB and λ5)
chronic lymphocytic leukemia (CD5+)
mature B cell